Low Dose Naltrexone and autoimmune diseases
Low Dose Naltrexone
"Some leading experts believe that low-dose naltrexone (LDN) holds great promise for the treatment of millions of people suffering with autoimmune diseases, central nervous system disorders, and even cancer and HIV/AIDS."
- Joseph Mercola, MD
As a result of a growing body of
evidence supporting Low Dose Naltrexone (LDN) in the treatment of a variety of autoimmune diseases such as
multiple sclerosis, many doctors and specialists are taking notice of this medication and prescribing it for their own patients.
If you believe this compounded medication may be right for you, talk to your doctor about Low Dose Naltrexone. Wedgewood Pharmacy compounds
LDN for patients when their doctors prescribe it. LDN has been prescribed for conditions such as AIDS, Autism, Crohn's Disease, Fibromyalgia, Multiple Sclerosis, Parkinson's Disease, Ovarian Cancer, and Rheumatoid Arthritis among others.
Low Dose Naltrexone patient information
There are plenty of great resources and online support groups for people taking LDN. You may want to learn more at informative and active sites such as
Links to studies on Low Dose Naltrexone
A recent article in Experimental Biology and Medicine reported that Naltrexone, an opioid antagonist, inhibits cell proliferation in vivo when utilized in a low dose. The article also reported that sequential administration of short-term Naltrexone and opioid growth factor had a greater inhibitory effect on cell proliferation than either agent alone.
Dr. Bernard Bihari is credited with pioneering the use of Low Dose Naltrexone for AIDS patients and opening the door for its use in cancer and autoimmune disease treatment. Wedgewood Pharmacy has posted some additional information on the drug Naltrexone with information on some more of the studies associated with LDN usage.
Dr. Mercola posted an article on his site, Mercola.com, about the use of Low Dose Naltrexone in the treatment of Crohn's Disease, among other diseases. In his comments, Dr. Mercola mentions the importance of endorphins in the success of LDN.